These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29311107)

  • 1. Considering transparency and value for fairer drug prices.
    Webster P
    CMAJ; 2018 Jan; 190(1):E30-E31. PubMed ID: 29311107
    [No Abstract]   [Full Text] [Related]  

  • 2. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards.
    Bendicksen L; Rome BN; Avorn J; Kesselheim AS
    Milbank Q; 2021 Dec; 99(4):1162-1197. PubMed ID: 34375015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maine Rx: the act to establish fairer prescription drug prices.
    Pingree C
    Minn Med; 2001 Jan; 84(1):48-9. PubMed ID: 11202525
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysts in India call for urgent expansion of essential medicines list.
    Jain A
    BMJ; 2014 Mar; 348():g2050. PubMed ID: 24620358
    [No Abstract]   [Full Text] [Related]  

  • 5. California's Drug Transparency Law: Navigating The Boundaries Of State Authority On Drug Pricing.
    Gudiksen KL; Brown TT; Whaley CM; King JS
    Health Aff (Millwood); 2018 Sep; 37(9):1503-1508. PubMed ID: 30179546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness evaluation of drugs: multidisciplinary collaboration and transparency are key].
    Mueller EA; Kirch W
    Med Klin (Munich); 2008 Oct; 103(10):712-6. PubMed ID: 18936896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The States as Important Laboratories for Federal Prescription Drug Cost-Containment Efforts.
    Horvath JC; Anderson GF
    JAMA; 2019 Apr; 321(16):1561-1562. PubMed ID: 31012941
    [No Abstract]   [Full Text] [Related]  

  • 8. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices.
    Pinzone JD
    J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulator or regulatory shield? The case for reforming Canada's Patented Medicine Prices Review Board.
    Zhang R; Martin D; Naylor CD
    CMAJ; 2017 Apr; 189(14):E515-E516. PubMed ID: 28396326
    [No Abstract]   [Full Text] [Related]  

  • 10. Plenty of green in gray market. There's more at issue than just inflated prices for drugs in short supply.
    May D
    Mod Healthc; 2011 Oct; 41(42):25. PubMed ID: 22049782
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medication prices in Germany--how are they determined?].
    Bruhn C
    Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
    [No Abstract]   [Full Text] [Related]  

  • 12. Value-Based Pricing and State Reform of Prescription Drug Costs.
    Hwang TJ; Kesselheim AS; Sarpatwari A
    JAMA; 2017 Aug; 318(7):609-610. PubMed ID: 28692713
    [No Abstract]   [Full Text] [Related]  

  • 13. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drug prices in the US.
    Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
    [No Abstract]   [Full Text] [Related]  

  • 15. State Initiatives to Control Medication Costs--Can Transparency Legislation Help?
    Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2016 Jun; 374(24):2301-4. PubMed ID: 27305189
    [No Abstract]   [Full Text] [Related]  

  • 16. 3 New England states prescribe innovative ways to cut drug prices.
    Carlson B
    Manag Care; 2000 Dec; 9(12):17-8. PubMed ID: 11188356
    [No Abstract]   [Full Text] [Related]  

  • 17. Opinion: The high cost of low drug prices.
    Franks B
    N J Med; 2004; 101(7-8):56, 55. PubMed ID: 15373148
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug Costs: The Controversy Continues.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2017 Mar; 31(1):2-3. PubMed ID: 28287362
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting Unconscionable Prescription-Drug Prices - Maryland's Anti-Price-Gouging Law.
    Greene JA; Padula WV
    N Engl J Med; 2017 Jul; 377(2):101-103. PubMed ID: 28591520
    [No Abstract]   [Full Text] [Related]  

  • 20. Fair global drug pricing.
    Campbell JD; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):581-583. PubMed ID: 30215535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.